These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 934232)

  • 1. Letter: Ascites in malignant melanoma after oral BCG immunotherapy.
    Nutting MG; McPherson TA
    N Engl J Med; 1976 Aug; 295(7):395. PubMed ID: 934232
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary inoculation tuberculosis after immunotherapy for malignant melanoma with BCG vaccine.
    Caplan SE; Kauffman CL
    J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):783-5. PubMed ID: 8912582
    [No Abstract]   [Full Text] [Related]  

  • 3. Granulomatous hepatitis caused by B.C.G. injection during immunotherapy of a malignant melanoma.
    Serrou B; Michel H; Dubois JB; Serre A
    Biomedicine; 1975 Jun; 23(6):236-40. PubMed ID: 764894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCG immunotherapy in previously treated malignant melanoma patients.
    Mujagić H; Kolarić K; Malenica B; Nola P
    Biomedicine; 1979 Jun; 30(2):95-102. PubMed ID: 476270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of the complications occurring in BCG vaccine immunotherapy of patients with malignant neoplasms].
    Grigorovich NA; Risina DIa; Nodel'son SE
    Vopr Onkol; 1984; 30(7):102-6. PubMed ID: 6464396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with BCG adjuvant immunotherapy in stage II malignant melanoma.
    Peter HH; Deutschmann EM; Schultheis W; Deicher H
    Dev Biol Stand; 1977 Apr 13-15; 38():537-40. PubMed ID: 344106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of oral and intraperitoneal BCG in the treatment of malignant melanoma and adenocarcinoma.
    Falk RE; Landi S; Cohen Z; Falk JA; Ambus UA; Langer B
    Can J Otolaryngol; 1975; 4(1):39-45. PubMed ID: 1093646
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant immunostimulation in malignant melanoma with oral Bacille Calmette-Guérin.
    MacGregor AB; Falk RE; Landi S; Ambus U; Samuel ES; Langer B
    Can J Surg; 1977 Jan; 20(1):25-30. PubMed ID: 832200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distant cutaneous granulomas after bacille Calmette-Guérin immunotherapy for malignant melanoma: case for direct infection.
    Moff SL; Corey GR; Gottfredsson M
    Clin Infect Dis; 1999 Dec; 29(6):1569-70. PubMed ID: 10585816
    [No Abstract]   [Full Text] [Related]  

  • 10. Erythema multiforme as a complication of BCG scarification technique.
    Tschen EH; Jessen RT; Robertson G; Becker LE
    Arch Dermatol; 1979 May; 115(5):614-5. PubMed ID: 443840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous lupus erythematosus associated with melanoma and BCG vaccine therapy.
    Herstoff JK; Bogaars HA
    Arch Dermatol; 1979 Jul; 115(7):856-9. PubMed ID: 453895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multiple BCG-induced ulcers after subcutaneous vaccination in the framework of immunochemotherapy in malignant melanoma].
    Korting HC; Strasser S; Konz B
    Hautarzt; 1988 Mar; 39(3):170-3. PubMed ID: 3378889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral bacille Calmette Guérin immunostimulation in malignant melanoma.
    MacGregor AB; Falk RE; Landi S; Ambus U; Langer B
    Surg Gynecol Obstet; 1975 Nov; 141(5):747-54. PubMed ID: 1105837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant BCG immunotherapy for stage I and II malignant melanoma.
    Silver HK; Ibrahim EM; Evers JA; Thomas JW; Murray RN; Spinelli JJ
    Can Med Assoc J; 1983 Jun; 128(11):1291-5. PubMed ID: 6342739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of immunotherapy in the treatment of malignant melanoma of the skin].
    Kristensen E
    Ugeskr Laeger; 1976 Feb; 138(8):468-73. PubMed ID: 1258215
    [No Abstract]   [Full Text] [Related]  

  • 16. Miliary pulmonary granulomas induced by the methanol extraction residue of BCG (MER/BCG) in patients with melanoma.
    Bartal AH; Adler O; Cohen Y; Robinson E
    Indian J Cancer; 1982; 19(5):267-71. PubMed ID: 7166346
    [No Abstract]   [Full Text] [Related]  

  • 17. Active immunotherapy with B.C.G. for melanoma.
    Thompson RB
    Panminerva Med; 1975; 17(5-6):189-92. PubMed ID: 1161318
    [No Abstract]   [Full Text] [Related]  

  • 18. [Side effects of BCG immune therapy in 511 patients with malignant melanoma].
    Schult C
    Hautarzt; 1984 Feb; 35(2):78-83. PubMed ID: 6706581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined immunotherapy of malignant melanoma. Unusual survival following cerebral metastasis.
    Spitler LE; Wong P; Sagebiel R
    Arch Dermatol; 1978 Oct; 114(10):1501-4. PubMed ID: 718187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma.
    Eilber FR; Morton DL; Holmes EC; Sparks FC; Ramming KP
    N Engl J Med; 1976 Jan; 294(5):237-40. PubMed ID: 1244548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.